UPDATE 1 — EMA panel backs approval of Revolution's pancreatic cancer drug
(Adds details throughout) Oct 15 (Reuters) — A European Medicines Agency committee on Thursday recommended approval of Revolution Medicines' Rasonque in the EU for adults with pancreatic cancer that has spread and worsened after at least one prior treatment. Rasonque was approved in the US in August using an expedited